CN105219795A - A kind of colibacillary method of ultrasonic assistant gene transformation - Google Patents
A kind of colibacillary method of ultrasonic assistant gene transformation Download PDFInfo
- Publication number
- CN105219795A CN105219795A CN201510594884.2A CN201510594884A CN105219795A CN 105219795 A CN105219795 A CN 105219795A CN 201510594884 A CN201510594884 A CN 201510594884A CN 105219795 A CN105219795 A CN 105219795A
- Authority
- CN
- China
- Prior art keywords
- escherichia coli
- transformation
- exogenous gene
- coli
- assisted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000009466 transformation Effects 0.000 title claims abstract description 50
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 25
- 241000588724 Escherichia coli Species 0.000 claims abstract description 59
- 239000013612 plasmid Substances 0.000 claims abstract description 28
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000006285 cell suspension Substances 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000013613 expression plasmid Substances 0.000 claims abstract description 9
- 238000002604 ultrasonography Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 108010089254 Cholesterol oxidase Proteins 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 230000003698 anagen phase Effects 0.000 claims description 6
- 230000001131 transforming effect Effects 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 19
- 102000004190 Enzymes Human genes 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 19
- 238000011426 transformation method Methods 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 31
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 238000012216 screening Methods 0.000 description 14
- 239000013642 negative control Substances 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 238000001502 gel electrophoresis Methods 0.000 description 7
- 238000012795 verification Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- NYOXRYYXRWJDKP-GYKMGIIDSA-N cholest-4-en-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 NYOXRYYXRWJDKP-GYKMGIIDSA-N 0.000 description 3
- NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108700005443 Microbial Genes Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种超声波辅助外源基因转化大肠杆菌的方法,所述方法为:将携带外源基因的表达质粒与大肠杆菌感受态细胞悬液混合,调节pH值至6.5~7.5,在35~37℃、超声波场强200~500W的条件下进行转化反应,转化反应结束后,筛选获得含外源基因的大肠杆菌的阳性转化子;所述大肠杆菌感受态细胞悬液是由大肠杆菌感受态细胞与二甲基亚砜混合而成;本发明所述超声波诱导基因转化方法更加环保,不依赖于细胞型,且转化率和电转化率相当,转化率达2.6×104阳性转化子/μg质粒DNA,其中产量最高的重组菌株的酶活达到1.22U/mL,较出发菌株的酶活提高了144%。The invention discloses a method for ultrasonically assisted exogenous gene transformation of Escherichia coli. The method comprises: mixing an expression plasmid carrying an exogenous gene with Escherichia coli competent cell suspension, adjusting the pH value to 6.5-7.5, The transformation reaction is carried out under the conditions of ~37°C and ultrasonic field strength of 200 ~ 500W. After the transformation reaction is completed, positive transformants of E. coli containing exogenous genes are screened; the E. coli competent cell suspension is obtained by E. coli. mixed with dimethyl sulfoxide; the ultrasound-induced gene transformation method of the present invention is more environmentally friendly, does not depend on the cell type, and the transformation rate is equivalent to the electric transformation rate, and the transformation rate reaches 2.6×10 4 positive transformants/ μg of plasmid DNA, the enzyme activity of the recombinant strain with the highest yield reached 1.22U/mL, which was 144% higher than that of the original strain.
Description
(一)技术领域(1) Technical field
本发明涉及外源基因导入微生物的方法,尤其涉及一种将构建的含有外源基因的质粒导入大肠杆菌的高效超声波转化方法。The invention relates to a method for introducing exogenous genes into microorganisms, in particular to a high-efficiency ultrasonic transformation method for introducing constructed plasmids containing exogenous genes into Escherichia coli.
(二)背景技术(2) Background technology
胆固醇广泛存在于动物体内,尤以脑及神经组织中最为丰富,在肾、脾、皮肤、肝和胆汁中含量也高。其溶解性与脂肪类似,不溶于水,易溶于乙醚、氯仿等溶剂。胆固醇是动物组织细胞所不可缺少的重要物质,它不仅参与形成细胞膜,而且是合成胆汁酸,维生素D以及甾体激素的原料。胆固醇经代谢还能转化为胆汁酸、类固醇激素、7-脱氢胆固醇,并且7-脱氢胆固醇经紫外线照射就会转变为维生素D3,所以胆固醇并非是对人体有害的物质。但当其过量时便会导致高胆固醇血症,对机体产生不利的影响。现代研究已发现,动脉粥样硬化、静脉血栓形成与胆石症与高胆固醇血症有密切的相关性。胆固醇氧化酶可以将胆固醇氧化为胆甾-4-烯-3-酮。应用胆固醇氧化酶的氧化性质可以建立酶法检测胆固醇含量的检测体系。此外,胆固醇的氧化产物胆甾-4-烯-3-酮具有防心血病、抑制皮肤角质化、治疗肝病和防止肥胖等药效。因此,胆固醇氧化酶是一种具有多种功能和用途的酶类,其主要来源于微生物。Cholesterol is widely present in animals, especially in brain and nerve tissue, and is also high in kidney, spleen, skin, liver and bile. Its solubility is similar to that of fat, insoluble in water, and easily soluble in solvents such as ether and chloroform. Cholesterol is an indispensable and important substance in animal tissue cells. It not only participates in the formation of cell membranes, but also is a raw material for the synthesis of bile acids, vitamin D and steroid hormones. Cholesterol can also be converted into bile acid, steroid hormones, and 7-dehydrocholesterol after metabolism, and 7-dehydrocholesterol can be converted into vitamin D3 after ultraviolet radiation, so cholesterol is not a harmful substance to the human body. But when it is excessive, it will cause hypercholesterolemia, which will have adverse effects on the body. Modern research has found that atherosclerosis, venous thrombosis, cholelithiasis and hypercholesterolemia are closely related. Cholesterol oxidase can oxidize cholesterol to cholest-4-en-3-one. Using the oxidizing property of cholesterol oxidase, a detection system for enzymatic detection of cholesterol content can be established. In addition, the oxidized product of cholesterol, cholest-4-en-3-one, has the effects of preventing heart disease, inhibiting skin keratinization, treating liver disease and preventing obesity. Therefore, cholesterol oxidase is an enzyme with various functions and uses, which is mainly derived from microorganisms.
野生菌的产酶能力在300U/L左右,满足不了工业生产要求。所以,学者们一直在对菌种进行改造并优化发酵条件,以提高菌种产酶活力、胆固醇氧化酶的分离纯化及应用。目前都集中在通过基因工程方法来提高胆固醇氧化酶产量。而常规的基因工程方法要求有高端仪器设备,所用试剂昂贵且大多对人体和环境有害,超声波作为一种物理方法可以解决这种不利。The enzyme production ability of wild bacteria is about 300U/L, which cannot meet the requirements of industrial production. Therefore, scholars have been transforming the strains and optimizing the fermentation conditions to improve the enzyme production activity of the strains, the separation, purification and application of cholesterol oxidase. At present, they are all focused on improving the production of cholesterol oxidase through genetic engineering methods. Conventional genetic engineering methods require high-end instruments and equipment, and the reagents used are expensive and most of them are harmful to the human body and the environment. Ultrasound, as a physical method, can solve this disadvantage.
超声技术是学术界、工程界公认的高新技术与未来产业之一,近年来,这项高新技术才随着物理、机械、电子、材料学的长足进步及许多边缘或交叉工业领域的需求,得到迅猛发展。上世纪八十年代以来,超声技术不断应用于工业、农业、医药卫生等领域。超声波技术应用于生物学领域,已经涉及到细胞的破碎,灭菌,提取胞内物质,利用微超声波增强细胞内酶的生产和提高非水相酶催化的均质效应以及改善细胞的壁膜结构,增加通透性以及对液体中固形物或液体浓度的在线检测等。适当控制超声波作用的强度和频率,可使之对工业微生物产生正面效应,提高工业微生物发酵过程的效率。超声波转化是一种高效的将外源基因导入宿主的方法,目前在哺乳动物和植物中应用较多,而在微生物上鲜见报道。Ultrasonic technology is recognized as one of the high-tech and future industries in academia and engineering circles. In recent years, this high-tech has been obtained along with the great progress of physics, machinery, electronics, materials science and the needs of many marginal or cross-industrial fields. Rapid development. Since the 1980s, ultrasonic technology has been continuously applied in the fields of industry, agriculture, medicine and health. The application of ultrasonic technology in the field of biology has involved the crushing of cells, sterilization, extraction of intracellular substances, the use of micro-ultrasonic waves to enhance the production of intracellular enzymes and improve the homogeneous effect of non-aqueous phase enzyme catalysis and improve the wall membrane structure of cells , increase permeability and online detection of solid or liquid concentration in liquid, etc. Appropriate control of the intensity and frequency of ultrasonic action can have a positive effect on industrial microorganisms and improve the efficiency of industrial microbial fermentation processes. Ultrasonic transformation is an efficient method for introducing foreign genes into hosts. It is currently widely used in mammals and plants, but rarely reported in microorganisms.
(三)发明内容(3) Contents of the invention
本发明提供一种超声波辅助外源基因转化大肠杆菌的方法,该方法新颖、转化条件温和、成本低、绿色环境,易于实现基因转化的方法,解决了现有方法转化率低,细胞活力低,易死亡等问题。The invention provides a method for transforming Escherichia coli assisted by an ultrasonic wave, which is novel, mild in transformation conditions, low in cost, green in environment, and easy to realize gene transformation, and solves the problem of low transformation rate and low cell viability in the existing method problems such as death.
本发明采用如下技术方案:The present invention adopts following technical scheme:
本发明提供一种超声波辅助外源基因转化大肠杆菌的方法,所述方法为:将携带外源基因的表达质粒与大肠杆菌感受态细胞悬液混合,调节pH值至6.5~7.5,在35~37℃、超声波场强200~500W的条件下进行转化反应,转化反应结束后,筛选获得含外源基因的大肠杆菌的阳性转化子;所述大肠杆菌感受态细胞悬液是由大肠杆菌感受态细胞与二甲基亚砜混合而成。The invention provides a method for ultrasonically assisted transformation of Escherichia coli with an exogenous gene. The method is as follows: mixing an expression plasmid carrying an exogenous gene with an Escherichia coli competent cell suspension, adjusting the pH value to 6.5-7.5, The transformation reaction is carried out under the conditions of 37°C and ultrasonic field strength of 200-500W. After the transformation reaction is completed, positive transformants of Escherichia coli containing exogenous genes are screened; Cells were mixed with dimethyl sulfoxide.
进一步,所述大肠杆菌感受态细胞悬液中湿菌体细胞含量为1×107~1×108个细胞/mL,二甲基亚砜体积终浓度1-4%。Further, the content of wet bacterial cells in the Escherichia coli competent cell suspension is 1×10 7 -1×10 8 cells/mL, and the final volume concentration of dimethyl sulfoxide is 1-4%.
进一步,所述转化反应在35~37℃、超声波场强200~500W的条件下反应10~30min。Further, the conversion reaction is carried out at 35-37° C. and an ultrasonic field strength of 200-500 W for 10-30 minutes.
进一步,所述携带外源基因的表达质粒中外源基因为胆固醇氧化酶基因,核苷酸序列为SEQIDNO.1所示。Further, the foreign gene in the expression plasmid carrying the foreign gene is cholesterol oxidase gene, and the nucleotide sequence is shown in SEQ ID NO.1.
atgaccgatagccgggcgaacagagccgatgcgactcggggggttgcatccgtctcacgccgtcgattccttgcgggcgcaggtctgaccgcgggagccatcgcgctctcgtcgatgtcgacctccgcctccgcagcccccagccgcaccctcgccgacggcgaccgcgtccctgccctcgtcatcggcagtggatacggcggtgccgtcgccgcgctgcggctgacgcaggccggtatccccacgcagatcgtcgagatgggccgcagctgggacaccccgggctccgacggcaagatcttctgcgggatgctcaaccccgacaagcgctcgatgcggttggccgacaagaccgatcagccggtcagcaacttcatgggcttcggcatcaacaagagcatcgaccggtacgtcggcgtcctcgactccgagcggttctccggcatcaaggtctaccagggccgcggcgtcggcggcggctcgctcgtcaacggcggtatggcagtcaccccgaagcgcaactacttcgaggagatcctgccgtcggtcgactcgaacgagatgtacaacaagtacttcccgcgcgccaacaccggtctgggtgtcaacaacatcgaccaggcgtggttcgagtccaccgagtggtacaagttcgcccgcaccggccgcaagaccgcccaacgttcgggtttcacaaccgctttcgtgcccaacgtgtacgacttcgagtacatgaagaaggaggctgccggccaggtcaccaagtcgggcctcggcggtgaggtcatctacggcaacaacgccggcaagaagtcgctcgacaagacctacctcgcgcaggccgcggccaccgggaagctgacgatcacgactttgcaccgcgtcaccaaggtcgcgccggccaccggcagcggctacagcgtgacgatggaacagatcgacgagcagggcaacgtcgtcgccaccaaggtcgtcaccgccgatcgggtgttcttcgcggccggcagcgtcggcaccagcaagctcctggtctcgatgaaggcgcagggccacctgccgaacctgtcgtcgcaagtcggcgagggctggggcaacaacggcaacatcatggtgggccgcgcgaaccacatgtgggacgccaccggatccaagcaggccaccatcccgacgatgggaatcgacaactgggccgacccggcggcaccgatcttcgcggagatcgccccgctgccggccgggctcgagacctacgtcagcctgtacctggccatcacgaagaaccccgaacgtgctcgcttccagttcaattcgggcaccggcaaggtcgatctcacctgggctcagtcgcagaaccagaagggcatcgacatggccaagaaggtgttcgacaagatcaaccagaaggaaggcacgatctaccggaccgatctgttcggcgtgtacaagacgtggggcgacgacttcacgtaccacccgctgggcggcgtgctgctgaacaaggcgaccgacaacttcggccgcctgcccgagtaccccgggctgtacgtggtggacggctcgctcgtccccggcaatgtcggcgtcaacccgttcgtcacgatcaccgcgctcgccgagcgcaacatggacaagatcatctcgtccgacatccagtga。atgaccgatagccgggcgaacagagccgatgcgactcggggggttgcatccgtctcacgccgtcgattccttgcgggcgcaggtctgaccgcgggagccatcgcgctctcgtcgatgtcgacctccgcctccgcagcccccagccgcaccctcgccgacggcgaccgcgtccctgccctcgtcatcggcagtggatacggcggtgccgtcgccgcgctgcggctgacgcaggccggtatccccacgcagatcgtcgagatgggccgcagctgggacaccccgggctccgacggcaagatcttctgcgggatgctcaaccccgacaagcgctcgatgcggttggccgacaagaccgatcagccggtcagcaacttcatgggcttcggcatcaacaagagcatcgaccggtacgtcggcgtcctcgactccgagcggttctccggcatcaaggtctaccagggccgcggcgtcggcggcggctcgctcgtcaacggcggtatggcagtcaccccgaagcgcaactacttcgaggagatcctgccgtcggtcgactcgaacgagatgtacaacaagtacttcccgcgcgccaacaccggtctgggtgtcaacaacatcgaccaggcgtggttcgagtccaccgagtggtacaagttcgcccgcaccggccgcaagaccgcccaacgttcgggtttcacaaccgctttcgtgcccaacgtgtacgacttcgagtacatgaagaaggaggctgccggccaggtcaccaagtcgggcctcggcggtgaggtcatctacggcaacaacgccggcaagaagtcgctcgacaagacctacctcgcgcaggccgcggccaccgggaagctgacgatcacgactttgcaccgcgtcaccaaggtcgcgccggccaccggcagcggctacagcgtgacgatggaacagatcgacgagcagggcaacgtcgtcgccaccaaggtcgtcaccgccgatcgggtgttcttcgcgg ccggcagcgtcggcaccagcaagctcctggtctcgatgaaggcgcagggccacctgccgaacctgtcgtcgcaagtcggcgagggctggggcaacaacggcaacatcatggtgggccgcgcgaaccacatgtgggacgccaccggatccaagcaggccaccatcccgacgatgggaatcgacaactgggccgacccggcggcaccgatcttcgcggagatcgccccgctgccggccgggctcgagacctacgtcagcctgtacctggccatcacgaagaaccccgaacgtgctcgcttccagttcaattcgggcaccggcaaggtcgatctcacctgggctcagtcgcagaaccagaagggcatcgacatggccaagaaggtgttcgacaagatcaaccagaaggaaggcacgatctaccggaccgatctgttcggcgtgtacaagacgtggggcgacgacttcacgtaccacccgctgggcggcgtgctgctgaacaaggcgaccgacaacttcggccgcctgcccgagtaccccgggctgtacgtggtggacggctcgctcgtccccggcaatgtcggcgtcaacccgttcgtcacgatcaccgcgctcgccgagcgcaacatggacaagatcatctcgtccgacatccagtga。
进一步,所述大肠杆菌为大肠杆菌E.coli(DE3),购自Novagen公司。Further, the Escherichia coli is Escherichia coli E.coli (DE3), purchased from Novagen.
进一步,所述携带外源基因的表达质粒与大肠杆菌感受态细胞悬液体积比为1:40-55,所述大肠杆菌感受态细胞悬液中湿菌体细胞含量为1×107~1×108个细胞/mL。Further, the volume ratio of the expression plasmid carrying the exogenous gene to the Escherichia coli competent cell suspension is 1:40-55, and the content of wet bacterial cells in the Escherichia coli competent cell suspension is 1×10 7 ~1 ×10 8 cells/mL.
进一步,所述大肠杆菌感受态细胞按如下步骤制备:将大肠杆菌接种至LB液体培养基中,180~220r/min,35~37℃振荡培养至指数生长期(通常培养2.5~10h),12000r/min,10~15min,4℃离心,收集湿菌体,获得大肠杆菌感受态细胞。Further, the Escherichia coli competent cells are prepared according to the following steps: inoculate Escherichia coli into LB liquid medium, 180-220r/min, shake culture at 35-37°C until exponential growth phase (usually 2.5-10h), 12000rr /min, 10-15min, centrifuge at 4°C, collect the wet cells, and obtain Escherichia coli competent cells.
进一步,所述携带胆固醇氧化酶基因的表达质粒为pET28a-choB载体质粒。Further, the expression plasmid carrying the cholesterol oxidase gene is a pET28a-choB vector plasmid.
本发明所述超声波辅助外源基因转化大肠杆菌的方法,具体按如下步骤进行:The method for ultrasonic-assisted exogenous gene transformation Escherichia coli described in the present invention is specifically carried out as follows:
(1)大肠杆菌感受态细胞的培养和收集(1) Cultivation and collection of Escherichia coli competent cells
挑取大肠杆菌(优选大肠杆菌E.coli(DE3))单菌落,接种至LB液体培养基中,180~220r/min,35~37℃振荡培养至指数生长期(通常培养2.5-20h),12000r/min,10~15min,4℃离心,收集湿菌体,获得大肠杆菌感受态细胞;Pick a single colony of Escherichia coli (preferably Escherichia coli E.coli (DE3)), inoculate it into LB liquid medium, and cultivate it with shaking at 180-220r/min, 35-37°C until the exponential growth phase (usually 2.5-20h), 12000r/min, 10-15min, centrifuge at 4°C, collect the wet cells, and obtain Escherichia coli competent cells;
(2)以大肠杆菌为宿主的基因转化研究(2) Gene transformation research using Escherichia coli as host
向大肠杆菌感受态细胞中加入二甲基亚砜使湿菌体细胞含量为1×107~1×108个细胞/mL(二甲基亚砜体积终浓度为1-4%),添加携带胆固醇氧化酶基因的pET28a载体质粒,在pH值至6.5~7.5、35~37℃、超声波场强200~500W下,经超声波作用进行转化反应,分别考察场强和处理时间等参数对转化的影响;Add dimethyl sulfoxide to E. coli competent cells so that the content of wet bacterial cells is 1×10 7 ~1×10 8 cells/mL (the final volume concentration of dimethyl sulfoxide is 1-4%), add The pET28a carrier plasmid carrying the cholesterol oxidase gene was transformed by ultrasonic waves at a pH value of 6.5-7.5, 35-37°C, and an ultrasonic field strength of 200-500W. The effect of parameters such as field strength and treatment time on the transformation influences;
(3)阳性转化子的筛选(3) Screening of positive transformants
当转化结束后,将转化后的菌液涂布到含50~100μg/mLKan和50~100μg/mL的LB平板上,35~37℃培养24~48小时进行筛选,得到阳性转化子;When the transformation is completed, spread the transformed bacterial solution onto an LB plate containing 50-100 μg/mL Kan and 50-100 μg/mL, and culture at 35-37°C for 24-48 hours for screening to obtain positive transformants;
(4)阳性转化子的鉴定(4) Identification of positive transformants
随机选取转化平板上的转化子提取基因组DNA,以其为模板,采用特异性引物进行PCR验证。所用引物:5'-TTCCATGGCCGATAGCCGGGCGAACAG-3'和5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'。PCR反应条件为:94℃5min;94℃30s,55℃30s,72℃1min,30个循环;72℃5min;凝胶电泳检测重组载体是否插入大肠杆菌基因组。Randomly select transformants on the transformation plate to extract genomic DNA, use it as a template, and use specific primers for PCR verification. Primers used: 5'-TTCCATGGCCGATAGCCGGGCGAACAG-3' and 5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'. The PCR reaction conditions were: 94°C for 5min; 30 cycles of 94°C for 30s, 55°C for 30s, 72°C for 1min; 72°C for 5min; gel electrophoresis was used to detect whether the recombinant vector was inserted into the E. coli genome.
(5)产物表达和稳定性研究(5) Product expression and stability research
鉴定好的转化子接种到含50~100μg/mLKan和50~100μg/mL的LB液体培养基中,在35~37℃培养12~15小时后,加IPTG至终浓度为0.1~0.6mmol/L,继续培养3~5h,检测胆固醇氧化酶酶活。The identified transformants were inoculated into LB liquid medium containing 50-100 μg/mL Kan and 50-100 μg/mL, cultured at 35-37°C for 12-15 hours, and then added IPTG to a final concentration of 0.1-0.6 mmol/L , continue culturing for 3-5 hours, and detect the enzyme activity of cholesterol oxidase.
与现有技术相比,本发明有益效果主要体现在:Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:
1)目前报道多集中在超声诱导植物和动物基因转化,本发明拟以超声波方法诱导微生物基因转化。1) At present, most reports focus on ultrasound-induced gene transformation of plants and animals. The present invention intends to use ultrasound to induce microbial gene transformation.
2)常用的基因转化方法有基因工程法和电穿孔法,基因工程法要求有高端仪器设备,所用试剂昂贵且大多对人体和环境有害;电穿孔要求有较低的离子介质和较高的电压,并且接合要求有直接细胞-细胞接触。本发明所述超声波诱导基因转化方法更加环保,不依赖于细胞型,且转化率和电转化率相当。本发明与现有的电转化方法相比除具有上述优势外,转化效率也与电转化相当或高于电转化,如一种将穿梭质粒导入黄色短杆菌的电转化方法(CN1718732A)的转化率为2.0×103,本发明转化率达2.6×104阳性转化子/μg质粒DNA,其中产量最高的重组菌株的酶活达到1.22U/mL,较出发菌株的酶活提高了144%。2) Commonly used gene transformation methods include genetic engineering and electroporation. Genetic engineering requires high-end instruments and equipment, and the reagents used are expensive and mostly harmful to the human body and the environment; electroporation requires lower ionic media and higher voltage , and conjugation requires direct cell-cell contact. The ultrasonic-induced gene transformation method of the present invention is more environmentally friendly, does not depend on the cell type, and the transformation rate is equivalent to the electric transformation rate. Compared with the existing electrotransformation method, the present invention has the above-mentioned advantages, and the transformation efficiency is also equivalent to or higher than that of electrotransformation. For example, the transformation rate of an electrotransformation method (CN1718732A) that introduces a shuttle plasmid into Brevibacterium flavum is 2.0×10 3 , the conversion rate of the present invention reaches 2.6×10 4 positive transformants/μg plasmid DNA, and the enzyme activity of the recombinant strain with the highest yield reaches 1.22U/mL, which is 144% higher than that of the original strain.
(四)附图说明(4) Description of drawings
图1为实施例1阳性转化子筛选凝胶电泳图,泳道M为Marker,泳道1为阳性转化子。Fig. 1 is the gel electrophoresis image of positive transformant screening in Example 1, swimming lane M is Marker, and swimming lane 1 is positive transformant.
图2为实施例2阳性转化子筛选凝胶电泳图,泳道M为Marker,泳道1为阳性转化子。Fig. 2 is the gel electrophoresis image of positive transformant screening in Example 2, swimming lane M is Marker, and swimming lane 1 is positive transformant.
图3为实施例3阳性转化子筛选凝胶电泳图,泳道M为Marker,泳道1为阳性转化子。Fig. 3 is the gel electrophoresis image of positive transformant screening in Example 3, swimming lane M is Marker, and swimming lane 1 is positive transformant.
(五)具体实施方式(5) Specific implementation methods
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此:The present invention is further described below in conjunction with specific embodiment, but protection scope of the present invention is not limited thereto:
LB液体培养基配方为:胰蛋白胨10g,酵母提取物5g,NaCl10g,用去离子水定容至1L。The formula of LB liquid medium is: tryptone 10g, yeast extract 5g, NaCl 10g, dilute to 1L with deionized water.
实施例1Example 1
(1)大肠杆菌感受态细胞的培养和收集(1) Cultivation and collection of Escherichia coli competent cells
挑取大肠杆菌E.coli(DE3)(购自Novagen公司)接种至LB培养基,180r/min,35℃振荡培养2.5h至指数生长期,12000r/min,10min,4℃离心,收集湿菌体,获得大肠杆菌感受态细胞。Pick Escherichia coli E.coli (DE3) (purchased from Novagen) and inoculate it into LB medium, shake at 180r/min at 35°C for 2.5h to the exponential growth phase, centrifuge at 12000r/min for 10min at 4°C, and collect wet bacteria To obtain Escherichia coli competent cells.
(2)以大肠杆菌为宿主的基因转化研究(2) Gene transformation research using Escherichia coli as host
将胆固醇氧化酶基因choB克隆到pET28a载体质粒上。The cholesterol oxidase gene choB was cloned into pET28a vector plasmid.
将步骤(1)获得的湿菌体与二甲基亚砜混合制成菌体浓度为1×108个/mL,二甲基亚砜的体积终浓度为2%的细胞悬液,将含胆固醇氧化酶基因choB的pET28a质粒(质粒浓度应不小于70ng/μL)与细胞悬液以体积比为1:40混合,即取0.5mL质粒与20mL细胞悬液混合,pH调至6.5;温度调至35℃,超声波场强为200W,处理时间为15min。The wet thallus obtained in step (1) is mixed with dimethyl sulfoxide to make a thalline concentration of 1 × 108 cells/mL, and the final concentration of dimethyl sulfoxide is 2% of the cell suspension. The pET28a plasmid of the cholesterol oxidase gene choB (plasmid concentration should not be less than 70ng/μL) was mixed with the cell suspension at a volume ratio of 1:40, that is, 0.5mL of the plasmid was mixed with 20mL of the cell suspension, and the pH was adjusted to 6.5; To 35°C, the ultrasonic field strength is 200W, and the processing time is 15min.
(3)阳性转化子的筛选和鉴定(3) Screening and identification of positive transformants
阳性转化子的筛选:将转化后的菌液涂布到含50μg/mLKan和50μg/mLCam的LB平板上,35℃培养24小时,进行平板筛选,获得阳性转化子。Screening of positive transformants: spread the transformed bacterial solution on an LB plate containing 50 μg/mLKan and 50 μg/mLCam, incubate at 35°C for 24 hours, perform plate screening, and obtain positive transformants.
阳性转化子的验证:随机选取转化平板上的转化子提取基因组DNA,以其为模板,采用特异性引物进行PCR验证。PCR反应条件为:94℃5min;94℃30s,55℃30s,72℃1min,30个循环;72℃5min。凝胶电泳检测重组载体是否插入大肠杆菌基因组,结果见图1。Verification of positive transformants: randomly select transformants on the transformation plate to extract genomic DNA, use it as a template, and use specific primers for PCR verification. The PCR reaction conditions are: 94°C for 5min; 30 cycles of 94°C for 30s, 55°C for 30s, 72°C for 1min; 72°C for 5min. Gel electrophoresis was used to detect whether the recombinant vector was inserted into the E. coli genome, and the results are shown in Figure 1.
所用引物:5'-TTCCATGGCCGATAGCCGGGCGAACAG-3'和5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'。Primers used: 5'-TTCCATGGCCGATAGCCGGGCGAACAG-3' and 5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'.
超声波转化同时设立阴性对照,阴性对照除不加质粒DNA外,其余过程与其它处理完全相同。在LB平板上阴性对照没有菌落生长的情况下,统计转化子数,计算转化效率。At the same time, a negative control was set up for ultrasonic transformation. Except that no plasmid DNA was added to the negative control, the rest of the process was exactly the same as other treatments. In the case of no colony growth in the negative control on the LB plate, count the number of transformants and calculate the transformation efficiency.
转化效率=转化子数/加入的质粒DNA量(μg)×稀释倍数。Transformation efficiency = number of transformants/amount of plasmid DNA added (μg) × dilution factor.
(4)产物表达(4) Product expression
鉴定好的阳性转化子接种到含50μg/mLKan和50μg/mLCam的LB液体培养基中,在35℃培养12小时达到对数生长期后,加IPTG至终浓度为0.2mmol/L,35℃继续培养3h,检测胆固醇氧化酶酶活(酶活定义为:37℃,1分钟转化1μmol胆固醇生成胆甾-4-烯-3-酮的酶量定义为1个酶活单位(U))。The identified positive transformants were inoculated into LB liquid medium containing 50 μg/mLKan and 50 μg/mLCam, cultured at 35°C for 12 hours to reach the logarithmic growth phase, then added IPTG to a final concentration of 0.2mmol/L, and continued at 35°C After culturing for 3 hours, the enzyme activity of cholesterol oxidase was detected (enzyme activity is defined as: the amount of enzyme that converts 1 μmol of cholesterol into cholest-4-en-3-one in 1 minute at 37°C is defined as 1 enzyme activity unit (U)).
上述发酵过程中,对所得的发酵液进行酶活分析,转化率为1.3×104阳性转化子/μg质粒DNA,其中产量最高的重组菌株(即含胆固醇氧化酶基因的大肠杆菌)的酶活达到1.12U/mL,较出发菌株提高了124%。During the above fermentation process, the obtained fermentation broth was analyzed for enzyme activity, and the conversion rate was 1.3×10 4 positive transformants/μg plasmid DNA, and the enzyme activity of the recombinant strain with the highest yield (ie Escherichia coli containing the cholesterol oxidase gene) was It reached 1.12U/mL, an increase of 124% compared with the starting strain.
实施例2Example 2
(1)大肠杆菌感受态细胞的培养和收集(1) Cultivation and collection of Escherichia coli competent cells
挑取大肠杆菌E.coli(DE3)(购自Novagen公司)接种至LB培养基,200r/min,36℃振荡培养20h至指数生长后期,12000r/min,10min,4℃离心,收集湿菌体,获得大肠杆菌感受态细胞。Pick Escherichia coli E.coli (DE3) (purchased from Novagen) and inoculate it into LB medium, culture with shaking at 200r/min at 36°C for 20h to the late stage of exponential growth, centrifuge at 12000r/min for 10min at 4°C, and collect the wet cells , to obtain Escherichia coli competent cells.
(2)以大肠杆菌为宿主的基因转化研究(2) Gene transformation research using Escherichia coli as host
将胆固醇氧化酶基因choB克隆到pET28a载体质粒上。The cholesterol oxidase gene choB was cloned into pET28a vector plasmid.
将步骤(1)获得的湿菌体与二甲基亚砜混合制成细胞含量为1×108个/mL,二甲基亚砜的体积终浓度为3%的细胞悬液,将含胆固醇氧化酶基因choB的pET28a质粒(质粒浓度应不小于70ng/μL)与细胞悬液以体积比为1:50混合,即取0.5mL质粒与25mL菌体悬液混合,pH调至7.0;温度调至36℃,超声波场强为500W,处理时间为30min。The wet thallus obtained in step (1) is mixed with dimethyl sulfoxide to make a cell suspension with a cell content of 1×10 8 cells/mL and a final volume concentration of dimethyl sulfoxide of 3%. The pET28a plasmid of the oxidase gene choB (plasmid concentration should not be less than 70ng/μL) was mixed with the cell suspension at a volume ratio of 1:50, that is, 0.5mL of the plasmid was mixed with 25mL of the cell suspension, and the pH was adjusted to 7.0; To 36°C, the ultrasonic field strength is 500W, and the treatment time is 30min.
(3)阳性转化子的筛选和鉴定(3) Screening and identification of positive transformants
阳性转化子的筛选:将转化后的菌液涂布到含80μg/mLKan和80μg/mLCam的LB平板上,36℃培养36小时,进行平板筛选,获得阳性转化子。Screening of positive transformants: spread the transformed bacterial solution on an LB plate containing 80 μg/mLKan and 80 μg/mLCam, incubate at 36°C for 36 hours, perform plate screening, and obtain positive transformants.
阳性转化子的验证:随机选取转化平板上的转化子提取基因组DNA,以其为模板,采用特异性引物进行PCR验证。PCR反应条件为:94℃5min;94℃30s,55℃30s,72℃1min,30个循环;72℃5min。凝胶电泳检测重组载体是否插入大肠杆菌基因组,结果见图2。Verification of positive transformants: randomly select transformants on the transformation plate to extract genomic DNA, use it as a template, and use specific primers for PCR verification. The PCR reaction conditions are: 94°C for 5min; 30 cycles of 94°C for 30s, 55°C for 30s, 72°C for 1min; 72°C for 5min. Gel electrophoresis was used to detect whether the recombinant vector was inserted into the E. coli genome, and the results are shown in Figure 2.
所用引物:5'-TTCCATGGCCGATAGCCGGGCGAACAG-3'和5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'。Primers used: 5'-TTCCATGGCCGATAGCCGGGCGAACAG-3' and 5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'.
超声波转化同时设立阴性对照,阴性对照除不加质粒DNA外,其余过程与其它处理完全相同。在LB平板上阴性对照没有菌落生长的情况下,统计转化子数,计算转化效率。At the same time, a negative control was set up for ultrasonic transformation. Except that no plasmid DNA was added to the negative control, the rest of the process was exactly the same as other treatments. In the case of no colony growth in the negative control on the LB plate, count the number of transformants and calculate the transformation efficiency.
转化效率=转化子数/加入的质粒DNA量(μg)×稀释倍数。Transformation efficiency = number of transformants/amount of plasmid DNA added (μg) × dilution factor.
(4)产物表达(4) Product expression
鉴定好的阳性转化子接种到含50μg/mLKan和50μg/mLCam的LB液体培养基中,在36℃培养14小时后,加IPTG至终浓度为0.4mmol/L,36℃继续培养4h,检测胆固醇氧化酶酶活。The identified positive transformants were inoculated into LB liquid medium containing 50 μg/mLKan and 50 μg/mLCam, cultured at 36°C for 14 hours, added IPTG to a final concentration of 0.4mmol/L, continued to culture at 36°C for 4h, and detected cholesterol Oxidase activity.
上述发酵过程中,对所得的发酵液进行酶活分析,转化率为2.6×104阳性转化子/μg质粒DNA,其中产量最高的重组菌株的酶活达到1.22U/mL,较出发菌株的酶活提高了144%。During the above fermentation process, the obtained fermentation broth was analyzed for enzyme activity, and the conversion rate was 2.6×10 4 positive transformants/μg plasmid DNA, and the enzyme activity of the recombinant strain with the highest yield reached 1.22 U/mL, which was higher than that of the original strain. Live increased by 144%.
实施例3Example 3
(1)大肠杆菌感受态细胞的培养和收集(1) Cultivation and collection of Escherichia coli competent cells
挑取大肠杆菌E.coli(DE3)(购自Novagen公司)接种至LB培养基,220r/min,37℃振荡培养8h后,12000r/min,15min,4℃离心,收集湿菌体,获得大肠杆菌感受态细胞。Pick Escherichia coli E.coli (DE3) (purchased from Novagen) and inoculate it into LB medium, shake it at 220r/min at 37°C for 8h, centrifuge at 12000r/min for 15min at 4°C, collect the wet cells, and obtain the large intestine Bacillus Competent Cells.
(2)以大肠杆菌为宿主的基因转化研究(2) Gene transformation research using Escherichia coli as host
将胆固醇氧化酶基因choB克隆到pET28a载体质粒上。The cholesterol oxidase gene choB was cloned into pET28a vector plasmid.
将步骤(1)获得的湿菌体与二甲基亚砜混合制成细胞含量为1×108个/mL,二甲基亚砜的体积终浓度为4%的细胞悬液,将含胆固醇氧化酶基因choB的pET28a质粒(质粒浓度应不小于70ng/μL)与细胞悬液以体积比为1:55混合,即取0.5mL质粒与27.5mL菌体悬液混合,pH调至7.5;温度调至37℃,超声波场强为500W,处理时间为30min。The wet thallus obtained in step (1) is mixed with dimethyl sulfoxide to make a cell suspension with a cell content of 1×10 8 cells/mL, and a final volume concentration of dimethyl sulfoxide of 4%. Mix the pET28a plasmid of the oxidase gene choB (plasmid concentration should not be less than 70ng/μL) with the cell suspension at a volume ratio of 1:55, that is, mix 0.5mL of the plasmid with 27.5mL of the cell suspension, and adjust the pH to 7.5; Adjust the temperature to 37°C, the ultrasonic field strength is 500W, and the treatment time is 30min.
(3)阳性转化子的筛选和鉴定(3) Screening and identification of positive transformants
阳性转化子的筛选:将转化后的菌液涂布到含100μg/mLKan和100μg/mLCam的LB平板上,37℃培养48小时,进行平板筛选,获得阳性转化子。Screening of positive transformants: spread the transformed bacterial solution onto an LB plate containing 100 μg/mLKan and 100 μg/mLCam, incubate at 37°C for 48 hours, perform plate screening, and obtain positive transformants.
阳性转化子的验证:随机选取转化平板上的转化子提取基因组DNA,以其为模板,采用特异性引物进行PCR验证。PCR反应条件为:94℃5min;94℃30s,55℃30s,72℃1min,30个循环;72℃5min。凝胶电泳检测重组载体是否插入大肠杆菌基因组,结果见图3。Verification of positive transformants: randomly select transformants on the transformation plate to extract genomic DNA, use it as a template, and use specific primers for PCR verification. The PCR reaction conditions are: 94°C for 5min; 30 cycles of 94°C for 30s, 55°C for 30s, 72°C for 1min; 72°C for 5min. Gel electrophoresis was used to detect whether the recombinant vector was inserted into the E. coli genome, and the results are shown in Figure 3.
所用引物:5'-TTCCATGGCCGATAGCCGGGCGAACAG-3'和5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'。Primers used: 5'-TTCCATGGCCGATAGCCGGGCGAACAG-3' and 5'-GCGAATTCTCACTGGATGTCGGACGAGATGA-3'.
超声波转化同时设立阴性对照,阴性对照除不加质粒DNA外,其余过程与其它处理完全相同。在LB平板上阴性对照没有菌落生长的情况下,统计转化子数,计算转化效率。At the same time, a negative control was set up for ultrasonic transformation. Except that no plasmid DNA was added to the negative control, the rest of the process was exactly the same as other treatments. In the case of no colony growth in the negative control on the LB plate, count the number of transformants and calculate the transformation efficiency.
转化效率=转化子数/加入的质粒DNA量(μg)×稀释倍数。Transformation efficiency = number of transformants/amount of plasmid DNA added (μg) × dilution factor.
(4)产物表达(4) Product expression
鉴定好的阳性转化子接种到含100μg/mLKan和100μg/mLCam的LB液体培养基中,在37℃培养15小时达到对数生长期后,加IPTG至终浓度为1.2mmol/L,37℃继续培养5h,检测胆固醇氧化酶酶活。The identified positive transformants were inoculated into LB liquid medium containing 100 μg/mLKan and 100 μg/mLCam, cultured at 37°C for 15 hours to reach the logarithmic growth phase, added IPTG to a final concentration of 1.2mmol/L, and continued at 37°C After culturing for 5 hours, the enzyme activity of cholesterol oxidase was detected.
上述发酵过程中,对所得的发酵液进行酶活分析,转化率为9.2×103阳性转化子/μg质粒DNA,其中产量最高的重组菌株的酶活达到1.16U/mL,较出发菌株的酶活提高了132%。During the above fermentation process, the obtained fermentation broth was analyzed for enzyme activity, and the conversion rate was 9.2×10 3 positive transformants/μg plasmid DNA, and the enzyme activity of the recombinant strain with the highest yield reached 1.16 U/mL, which was higher than that of the original strain. Live increased by 132%.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510594884.2A CN105219795A (en) | 2015-09-17 | 2015-09-17 | A kind of colibacillary method of ultrasonic assistant gene transformation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510594884.2A CN105219795A (en) | 2015-09-17 | 2015-09-17 | A kind of colibacillary method of ultrasonic assistant gene transformation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105219795A true CN105219795A (en) | 2016-01-06 |
Family
ID=54989061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510594884.2A Pending CN105219795A (en) | 2015-09-17 | 2015-09-17 | A kind of colibacillary method of ultrasonic assistant gene transformation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105219795A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115851443A (en) * | 2023-01-16 | 2023-03-28 | 中国科学院上海巴斯德研究所 | Low-temperature protection liquid for ultrasonic transformation of escherichia coli and cryopreservation method |
CN116162582A (en) * | 2022-08-30 | 2023-05-26 | 华南理工大学 | Drug-loaded bacterial ghost displaying acid-triggered rational membrane peptide, and preparation method and application thereof |
CN118028207A (en) * | 2024-04-15 | 2024-05-14 | 华南理工大学 | Preparation method of bacterial ghost, composition using bacterial ghost and preparation method of composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100196983A1 (en) * | 2009-02-05 | 2010-08-05 | Ut-Battelle, Llc | Transformation of gram positive bacteria by sonoporation |
CN101875947A (en) * | 2010-05-31 | 2010-11-03 | 中国科学院青岛生物能源与过程研究所 | An ultrasonic-mediated microbial genetic transformation method and its application |
-
2015
- 2015-09-17 CN CN201510594884.2A patent/CN105219795A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100196983A1 (en) * | 2009-02-05 | 2010-08-05 | Ut-Battelle, Llc | Transformation of gram positive bacteria by sonoporation |
CN101875947A (en) * | 2010-05-31 | 2010-11-03 | 中国科学院青岛生物能源与过程研究所 | An ultrasonic-mediated microbial genetic transformation method and its application |
Non-Patent Citations (1)
Title |
---|
YIZHI SONG ET AL.: "Ultrasound-mediated DNA transfer for bacteria", 《NUCLEIC ACIDS RESEARCH》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116162582A (en) * | 2022-08-30 | 2023-05-26 | 华南理工大学 | Drug-loaded bacterial ghost displaying acid-triggered rational membrane peptide, and preparation method and application thereof |
CN116162582B (en) * | 2022-08-30 | 2025-05-06 | 华南理工大学 | Drug-loaded bacterial shadow displaying acid-triggered rational membrane peptide and preparation method and application thereof |
CN115851443A (en) * | 2023-01-16 | 2023-03-28 | 中国科学院上海巴斯德研究所 | Low-temperature protection liquid for ultrasonic transformation of escherichia coli and cryopreservation method |
CN118028207A (en) * | 2024-04-15 | 2024-05-14 | 华南理工大学 | Preparation method of bacterial ghost, composition using bacterial ghost and preparation method of composition |
CN118028207B (en) * | 2024-04-15 | 2024-06-14 | 华南理工大学 | Preparation method of bacterial ghost, composition using bacterial ghost and preparation method of composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101275144B (en) | High-density fermentation and purification process for recombination high temperature-resistant hyperoxide dismutase | |
CN107916283B (en) | A kind of production technology of niacinamide | |
CN102296082A (en) | Construction method of escherichia coli genetic engineering bacteria for producing succinic acid by utilizing xylose metabolism | |
CN105219795A (en) | A kind of colibacillary method of ultrasonic assistant gene transformation | |
CN115806960B (en) | High-enzyme-activity pepsin artificial modified enzyme, and molecular modification method and expression application thereof | |
CN114644987B (en) | A kind of Aspergillus niger strain, method and application for improving L-malic acid production level and fermentation intensity | |
CN101186911A (en) | A method for constructing nitrile hydratase genetically engineered bacteria, as well as genetically engineered strains and applications | |
CN105274112B (en) | A kind of promoter of induced expression in acid condition | |
CN103849639B (en) | A kind of method improving halfcystine utilization ratio biosynthesis of glutathione | |
CN116463309A (en) | Caffeic acid-O-methyltransferase mutant, recombinant vector, recombinant bacteria, preparation method and application thereof | |
CN101613707B (en) | A method for producing glutathione with metabolic engineering bacteria | |
CN102604880A (en) | Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium | |
CN103087998B (en) | Enzyme for synthesizing cetyl-coenzyme A through cordyceps sinensis, gene and application thereof | |
CN102643774A (en) | Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium | |
CN112175839B (en) | D-pantoic acid lactone hydrolase, producing strain, genetic engineering strain and application thereof | |
CN103276038B (en) | Method for producing reagent grade peptone | |
CN105385614A (en) | Recombined saccharomyces cerevisiae and construction method and application thereof | |
CN117757762A (en) | Stropharia rugoso-annulata-derived fungal laccase, fungal laccase gene and application thereof | |
CN116024150A (en) | Genetic engineering strain for producing acetoin and construction method and application thereof | |
CN116376726A (en) | Identification method of target spot for improving gibberellin yield and application thereof | |
CN105316272A (en) | Ultrasonic-aided method for transforming exogenous genes into Brevibacterium sp. | |
CN105062906A (en) | Optimized organic phosphorus hydrolase yeast engineering bacteria and organic phosphorus hydrolase production | |
CN104450670A (en) | Method for improving enzyme-producing activity of host cells | |
CN113999807B (en) | Construction method of recombinant strain and application of recombinant strain in itaconic acid production | |
CN114854612B (en) | Transformation of Saccharomyces cerevisiae for producing L-lactic acid and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160106 |
|
RJ01 | Rejection of invention patent application after publication |